Review of data on the food additive aspartame
2013; European Food Safety Authority; Volume: 10; Issue: 3 Linguagem: Inglês
10.2903/sp.efsa.2013.en-399
ISSN2397-8325
Autores Tópico(s)Dye analysis and toxicity
ResumoEFSA Supporting PublicationsVolume 10, Issue 3 399E External scientific reportOpen Access Review of data on the food additive aspartame Dr Lesley Stanley, Dr Lesley StanleySearch for more papers by this author Dr Lesley Stanley, Dr Lesley StanleySearch for more papers by this author First published: 01 March 2013 https://doi.org/10.2903/sp.efsa.2013.EN-399Citations: 4 The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the European Food Safety Authority is subject. It may not be considered as an output adopted by EFSA. EFSA reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the authors. Published date: 1 March 2013 Question number: EFSA-Q-2011-00906 AboutPDF ToolsExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat References Abdel-Salam, O M, Salem, N A and Hussein, J S (2011). "Effect of Aspartame on Oxidative Stress and Monoamine Neurotransmitter Levels in Lipopolysaccharide-Treated Mice." Neurotox Res. Abdo, K M, Camargo, C A, Jr., Davis, D., Egilman, D., Epstein, S. S., Froines, J., Hattis, D., Hooper, K., Huff, J., Infante, P. F., Jacobson, M. F., Teitelbaum, D. T. and Tickner, J. A. (2007). "Letter to U.S. FDA commissioner. Questions about the safety of the artificial sweetener aspartame." Int J Occup Environ Health 13(4): 449– 450. Abegaz, E. G. and Soffritti, M. (2007). "Aspartame not linked to cancer." Environ Health Perspect 115(1): A16– 17; author reply A17. Abhilash, M., Paul, M. V., Varghese, M. V. and Nair, R. H. (2011). "Effect of long term intake of aspartame on antioxidant defense status in liver." Food Chem Toxicol 49(6): 1203– 1207. Akdas, A., Kirkali, Z. and Bilir, N. (1990). "Epidemiological case-control study on the etiology of bladder cancer in Turkey." Eur Urol 17(1): 23– 26. Al Suhaibani, E. S. (2010). "In vivo cytogenetic studies on aspartame." Comp Funct Genomics. Amery, W. K. (1988). "More on aspartame and headache." Headache 28(9): 624. Andress, J., Martinez, T. and Youkilis, G. (1973a). SC-19192: Acute Toxicity Studies in the Rat, Mouse and Rabbit. (Pathology-Toxicology). G.D. Searle & Co. Andress, J., Martinez, T. and Youkilis, G. (1973b). SC-18862: Acute Toxicity Studies in the Rat, Mouse and Rabbit. (Pathology-Toxicology). G.D. Searle & Co. Bandyopadhyay, A., Ghoshal, S. and Mukherjee, A. (2008). "Genotoxicity testing of low-calorie sweeteners: aspartame, acesulfame-K, and saccharin." Drug Chem Toxicol 31(4): 447– 457. Bantle, J. A., Fort, D. J., Rayburn, J. R., DeYoung, D. J. and Bush, S. J. (1990). "Further validation of FETAX: evaluation of the developmental toxicity of five known mammalian teratogens and non-teratogens." Drug Chem Toxicol 13(4): 267– 282. Beck, B., Burlet, A., Max, J. P. and Stricker-Krongrad, A. (2002). "Effects of long-term ingestion of aspartame on hypothalamic neuropeptide Y, plasma leptin and body weight gain and composition." Physiol Behav 75(1–2): 41– 47. Belogolovskaya, E. G., Oreshchenko, A. V., Durnev, A. D., Seredenin, S. B., Litvinova, E. V. and Zubtsov, Y. N. (2000). "Effects of beta-carotene and aspartame on clustogenic activity of cyclophosphamide and dioxidine in mice." Bull Exp Biol Med 130(11): 1102– 1105. Belpoggi, F., Soffritti, M., Padovani, M., Degli Esposti, D., Lauriola, M. and Minardi, F. (2006). "Results of long-term carcinogenicity bioassay on Sprague-Dawley rats exposed to aspartame administered in feed." Ann N Y Acad Sci 1076: 559– 577. Bergstrom, B. P., Cummings, D. R. and Skaggs, T. A. (2007). "Aspartame decreases evoked extracellular dopamine levels in the rat brain: an in vivo voltammetry study." Neuropharmacology 53(8): 967– 974. Bhagavan, N. V. (1975). "Letter: Hazards in indiscriminate use of sweeteners containing phenylalanine." N Engl J Med 292(1): 52– 53. Bigwood, E. J. (1975). "Letter: L-glutamic and L-aspartic acids–a question of hazard?" Food Cosmet Toxicol 13(2): 300– 301. Bleicher, S. J. and Stern, S. B. (N/K). Tolerance of Aspartame by Diabetic Subjects. G.D. Searle & Co. Bohn, S., Buchner, S. and Itin, P. (1997). "[Erythema nodosum: 112 cases. Epidemiology, clinical aspects and histopathology]." Schweiz Med Wochenschr 127(27–28): 1168– 1176. Bosetti, C., Gallus, S., Talamini, R., Montella, M., Franceschi, S., Negri, E. and La Vecchia, C. (2009). "Artificial sweeteners and the risk of gastric, pancreatic, and endometrial cancers in Italy." Cancer Epidemiol Biomarkers Prev 18(8): 2235– 2238. Bost, R. G. (1974). SC-18862: An Evaluation of the Mutagenic Potential Employing the Host-Mediated Assay in the Mouse (Pathology-Toxicology Project No. 1087S73) G.D. Searle & Co. Bost, R. G. and Stolt, R. A. (1974). SC-19192: An Evaluation of the Mutagenic Potential Employing the Host-Mediated Assay in the Mouse (Pathology-Toxicology Project No. 1095S73) G.D. Searle & Co. Bowles, C. A. and Jessup, D. C. (1970). Mutagenic Study in Rats. SC-18862. Final Report. (P-T 869H70). G.D. Searle & Co. Bradstock, M. K., Serdula, M. K., Marks, J. S., Barnard, R. J., Crane, N. T., Remington, P. L. and Trowbridge, F. L. (1986). "Evaluation of reactions to food additives: the aspartame experience." Am J Clin Nutr 43(3): 464– 469. Bravo, M. P., Del Rey-Calero, J. and Conde, M. (1987). "Risk factors of bladder cancer in Spain." Neoplasma 34(5): 633– 637. Bravo, M. P., Del Rey Calero, J. and Conde, M. (1987). "Bladder cancer and the consumption of alcoholic beverages in Spain." Eur J Epidemiol 3(4): 365– 369. Bressler, J. (1977). E-77/73 (P.T. 988573), SC-19192: 115 Week Oral Tumorigenicity Study in the Rat – Diketopiperazine. Inspection on behalf of Bureau of Foods. Bryan, G. T. (1973a). SC-18862: A 26 Week Urinary Bladder Tumorigenicity Study in the Mouse by the Intravesical Pellet Implant Technique. (P-T No. 1031ot72) Final Report. G.D. Searle & Co. Bryan, G. T. (1973b). SC-19192: A 26 Week Urinary Bladder Tumorigenicity Study in the Mouse by the Intravesical Pellet Implant Technique. (P-T Nos. 1032ot72 1036ot72, 1038ot72) Status Report. G.D. Searle & Co. Bryan, G. T. (1974a). SC-19192: A 56 Week Urinary Bladder Tumorigenicity Study in the Mouse by the Intravesical Pellet Implant Technique. (P-T Nos. 1034ot72, 1036ot72, 1038ot72) And Addendum to: A 26 Week Urinary Bladder Tumorigenicity Study in the Mouse by the Intravesical Pellet Implant Technique. (Project No. 1032ot72) Final Report. G.D. Searle & Co. Bryan, G. T. (1974b). SC-18862: A 56 Week Urinary Bladder Tumorigenicity Study in the Mouse by the Intravesical Pellet Implant Technique. (P-T Nos. 1033ot72, 1035ot72, 1037ot72) And Addendum to: A 26 Week Urinary Bladder Tumorigenicity Study in the Mouse by the Intravesical Pellet Implant Technique. (Project No. 1031ot72) Final Report. G.D. Searle & Co. Burgert, S. L., Andersen, D. W., Stegink, L. D., Takeuchi, H. and Schedl, H. P. (1991). "Metabolism of aspartame and its L-phenylalanine methyl ester decomposition product by the porcine gut." Metabolism 40(6): 612– 618. Burkhart, C. G. (2009). "'Lone' atrial fibrillation precipitated by monosodium glutamate and aspartame." Int J Cardiol 137(3): 307– 308. Burns, T., W.W., S. and Tschanz, C. (1987a). Effect of Repeated Ingestion of Beverage Containing Aspartame or Diketopiperazine on Amino Acid and Diketopiperazine Concentrations in Plasma and Urine of Normal Healthy Subjects. Protocol No. N02-84-02-075. Final Clinical Research Report. The Nutrasweet Company. Burns, T., W.W., S. and Tschanz, C. (1987b). Effect of Repeated Ingestion of Beverage Containing Aspartame or Diketopiperazine on Amino Acid and Diketopiperazine Concentrations in Subjects Heterozygous for Phenylketonuria. Protocol No. N12-85-02-054. Final Clinical Research Report. The Nutrasweet Company. Burns, T., W.W., S. and Tschanz, C. (1988). Safety of Long Term Aspartame Administration in Normal Subjects. Protocol No. N07-84-02-093. Final Clinical Research Report. The Nutrasweet Company. Burns, T. S., Stargel, W. W. and Hurwitz, A. (1990). "Bioavailability of phenylalanine and aspartate from aspartame (20 mg/kg) in capsules and solution." Metabolism 39(11): 1200– 1203. Burns, T. S., Stargel, W. W., Tschanz, C., Kotsonis, F. N. and Hurwitz, A. (1991). "Aspartame and sucrose produce a similar increase in the plasma phenylalanine to large neutral amino acid ratio in healthy subjects." Pharmacology 43(4): 210– 219. Bursey, R. G. and Watson, M. L. (2010). "Intake of artificially sweetened soft drinks and risk of preterm delivery." Am J Clin Nutr 92(5): 1277– 1278; author reply 1278–1280. Burton, E. G., Dal Monte, P., Spears, C., Frank, P. and Oppermann, J. A. (1984). "Absorption by the rhesus monkey of phenylalanine methyl ester and species differences in its metabolism by blood, plasma and intestinal mucosa." J Nutr 114(10): 1940– 1945. Burton, E. G., Schoenhard, G. L., Hill, J. A., Schmidt, R. E., Hribar, J. D., Kotsonis, F. N. and Oppermann, J. A. (1989). "Identification of N-beta-L-aspartyl-L-phenylalanine as a normal constituent of human plasma and urine." J Nutr 119(5): 713– 721. Butchko, H. H. (1994). "Adverse reactions to aspartame: double-blind challenge in patients from a vulnerable population by Walton et al." Biol Psychiatry 36(3): 206– 208. Butchko, H. H. (1997). "Safety of aspartame." Lancet 349(9058): 1105. Caballero, B., Mahon, B. E., Rohr, F. J., Levy, H. L. and Wurtman, R. J. (1986). "Plasma amino acid levels after single-dose aspartame consumption in phenylketonuria, mild hyperphenylalaninemia, and heterozygous state for phenylketonuria." J Pediatr 109(4): 668– 671. Cabaniols, C., Giorgi, R., Chinot, O., Ferahta, N., Spinelli, V., Alla, P., Barrie, M. and Lehucher-Michel, M. P. (2011). "Links between private habits, psychological stress and brain cancer: a case-control pilot study in France." J Neurooncol 103(2): 307– 316. Cain, D. P., Boon, F. and Bevan, M. (1989). "Failure of aspartame to affect seizure susceptibility in kindled rats." Neuropharmacology 28(4): 433– 435. Caldwell, J. C., Jinot, J., DeVoney, D. and Gift, J. S. (2008). "Evaluation of evidence for infection as a mode of action for induction of rat lymphoma." Environ Mol Mutagen 49(2): 155– 164. Caldwell, J. C., Jinot, J., Devoney, D. and Gift, J. S. (2009). "Response to letters to the editor: Caldwell et al. [2008]." Environmental and Molecular Mutagenesis 50(1): 6– 9. Camfield, P. R., Camfield, C. S., Dooley, J. M., Gordon, K., Jollymore, S. and Weaver, D. F. (1992). "Aspartame exacerbates EEG spike-wave discharge in children with generalized absence epilepsy: a double-blind controlled study." Neurology 42(5): 1000– 1003. Carlson, H. E. and Shah, J. H. (1989). "Aspartame and its constituent amino acids: effects on prolactin, cortisol, growth hormone, insulin, and glucose in normal humans." Am J Clin Nutr 49(3): 427– 432. Castanedo-Tardan, M. P., Gonzalez, M. E., Connelly, E. A., Giordano, K. and Jacob, S. E. (2009). "Systematized contact dermatitis and montelukast in an atopic boy." Pediatr Dermatol 26(6): 739– 743. Chamberlain, S. M., Balart, J. C., Sideridis, K., Salek, J., Sridhar, S. and Thompson, W. O. (2007). "Safety and efficacy of aspartame-based liquid versus sucrose-based liquids used for dilution in oral sodium phosphate solutions for colonoscopy preparations." Dig Dis Sci 52(11): 3165– 3168. Chiozzotto, D., Soffritti, M., Falcioni, L., Tibaldi, E., Manservisi, F., Manservigi, M., Bua, L. and Belpoggi, F. (2011). "Results of life span carcinogenicity bioassay on Sprague-Dawley rats exposed to aspartame since foetal life." Eur. J. Oncol. 16(2): 81– 97. Cho, E. S., Coon, J. D. and Stegink, L. D. (1987). "Plasma and urine diketopiperazine concentrations in normal adults ingesting large quantities of aspartame." Food Chem Toxicol 25(7): 499– 504. Christian, B., McConnaughey, K., Bethea, E., Brantley, S., Coffey, A., Hammond, L., Harrell, S., Metcalf, K., Muehlenbein, D., Spruill, W., Brinson, L. and McConnaughey, M. (2004). "Chronic aspartame affects T-maze performance, brain cholinergic receptors and Na+,K+-ATPase in rats." Pharmacol Biochem Behav 78(1): 121– 127. COC (2006). Committees on the Toxicity, Mutagenicity and Carcinogenicity of Chemicals in Food, Consumer Products and the Environment: Annual Report. Food Standards Agency, UK.: pp 277– 297. Colagiuri, S., Miller, J. J. and Edwards, R. A. (1989). "Metabolic effects of adding sucrose and aspartame to the diet of subjects with noninsulin-dependent diabetes mellitus." Am J Clin Nutr 50(3): 474– 478. Collins, T. F. X. (1978). Aspartame (SC-18862). Review of four studies submitted by G.D. Searle as entries to Food Additive Master File 134, in reponse to your memo of September 1, 1978. Memorandum to Charles Kokoski, Chief, Food Additives Evaluation Branch, HFF-185 from Collins, T. Whole Animal Toxicology Branch, HFF-155. US Food and Drug Administration. Cook, D. (1972). SC-18862 A Sweetening Agent. Pharmacological Studies. Searle Laboratories. COT (2010a). Methanol – Effects of inhalation exposure occupational levels (TOX/2010/24). Food Standards Agency, UK. COT (2010b). Chronic Toxicity of Methanol – Introduction (TOX/2010/04). Food Standards Agency, UK. COT (2010c). Chronic Toxicity of Methanol – Further Information (TOX/2010/12). Food Standards Agency, UK. COT (2011a). COT Statement on the Effects of Chronic Dietary Exposure to Methanol: Lay Summary. Food Standards Agency, UK. COT (2011b). COT Statement on the Effects of Chronic Dietary Exposure to Methanol. Food Standards Agency, UK. Coulombe, R. A., Jr. and Sharma, R. P. (1986). "Neurobiochemical alterations induced by the artificial sweetener aspartame (NutraSweet)." Toxicol Appl Pharmacol 83(1): 79– 85. Curtius, H. C., Endres, W. and Blau, N. (1994). "Effect of high-protein meal plus aspartame ingestion on plasma phenylalanine concentrations in obligate heterozygotes for phenylketonuria." Metabolism 43(4): 413– 416. Da Silva, L. C., Carvalho, T. S., Da Silva, F. B., Pires, R. F., Giugliani, R. and Pereira, M. L. (2000). "Aspartame loading test in PKU heterozygous individuals bearing severe and moderate mutations." Clin Genet 58(1): 86– 88. Daabees, T. T., Finkelstein, M. W., Stegink, L. D. and Applebaum, A. E. (1985). "Correlation of glutamate plus aspartate dose plasma amino-acid concentration and neuronal necrosis in infant mice." Food Chem Toxicol 23(10): 887– 894. Dailey, J. W., Lasley, S. M., Burger, R. L., Bettendorf, A. F., Mishra, P. K. and Jobe, P. C. (1991). "Amino acids, monoamines and audiogenic seizures in genetically epilepsy-prone rats: effects of aspartame." Epilepsy Res 8(2): 122– 133. Dailey, J. W., Lasley, S. M., Mishra, P. K., Bettendorf, A. F., Burger, R. L. and Jobe, P. C. (1989). "Aspartame fails to facilitate pentylenetetrazol-induced convulsions in CD-1 mice." Toxicol Appl Pharmacol 98(3): 475– 486. Davis, D. L., Ganter, L. and Weinkle, J. (2008). "Aspartame and incidence of brain malignancies." Cancer Epidemiol Biomarkers Prev 17(5): 1295– 1296. Davoli, E., Cappellini, L., Airoldi, L. and Fanelli, R. (1986). "Serum methanol concentrations in rats and in men after a single dose of aspartame." Food Chem Toxicol 24(3): 187– 189. Diomede, L., Romano, M., Guiso, G., Caccia, S., Nava, S. and Salmona, M. (1991). "Interspecies and interstrain studies on the increased susceptibility to metrazol-induced convulsions in animals given aspartame." Food Chem Toxicol 29(2): 101– 106. Dow-Edwards, D. L., Scribani, L. A. and Riley, E. P. (1989). "Impaired performance on odor-aversion testing following prenatal aspartame exposure in the guinea pig." Neurotoxicol Teratol 11(4): 413– 416. Drake, M. E. (1986). "Panic attacks and excessive aspartame ingestion." Lancet 2(8507): 631. Durnev, A. D., Oreshchenko, A. V., Kulakova, A. V., Beresten, N. F. and Seredenin, S. B. (1995). "[Clastogenic activity of dietary sugar substitutes]." Vopr Med Khim 41(4): 31– 33. Edmeads, J. (1988). "Aspartame and headache." Headache 28(1): 64– 65. EFSA (Euroepan Food Safety Authority), 2006. Opinion of the Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in contact with Food (AFC) on a request from the Commission related to a new long-term carcinogenicity study on aspartame (Question number EFSA-Q-2005-122). The EFSA Journal 2006, 356, 1– 44. EFSA (European Food Safety Auhtority), 2009a. Guidance of the Scientific Committee on Transparency in the Scientific Aspects of Risk Assessments carried out by EFSA. Part 2: General Principles. The EFSA Journal 2009, 1051, 1– 22. EFSA (European Food Safety Authority), 2009b. Scientific Opinion of the Panel on Food Additives and Nutrient Sources added to Food on a request from the European Commission related to the 2nd ERF carcinogenicity study on aspartame (EFSA-Q-2008-746). The EFSA Journal 2009, 945, 1– 18. EFSA (European Food Safety Authority), 2009c. Updated opinion on a request from the European Commission related to the 2nd ERF carcinogenicity study on aspartame, taking into consideration study data submitted by the Ramazzini Foundation in February 2009 (EFSA-Q-2009-00474). The EFSA Journal 2009, 1015, 1– 18. EFSA (European Food Safety Auhtority), 2011. EFSA Statement on the scientific evaluation of two studies related to the safety of artificial sweeteners. EFSA Journal 2011; 9(2):2089. [ 16 pp.] doi:10.2903/j.efsa.2011.2089. EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS), 2011. Scientific Opinion on two recent scientific articles on the safety of artificial sweeteners. EFSA Journal 2011; 9(2):1996. [ 5 pp.] doi:10.2903/j.efsa.2011.1996. Available online: www.efsa.europa.eu/efsajournal. EPA (2011). Toxicological Review of Methanol (Non-Cancer). (CAS No. 67-56-1) In Support of Summary Information on the Integrated Risk Information System (IRIS) (EPA/65/R-11/001). US Environmental Protection Agency. Eshel, Y. and Sarova-Pinhas, I. (1993). "Aspartame and seizures." Neurology 43(10): 2154– 2155. FDA (1976). Investigation covering preclinical animal studies conducted with Aspartame (L-aspartyl-L-phenylalanine methyl ester), a sweetening agent, and its breakdown product (metabolite) diketopiperazine (DKP). US Food and Drug Administration. FDA (2007). FDA Statement on European Aspartame Study. US Food and Drug Administration. Ferguson, H. B., Stoddart, C. and Simeon, J. G. (1986). "Double-blind challenge studies of behavioral and cognitive effects of sucrose-aspartame ingestion in normal children." Nutr Rev 44 Suppl: 144– 150. Ferguson, J. M. (1985). "Interaction of aspartame and carbohydrates in an eating-disordered patient." Am J Psychiatry 142(2): 271. Fernstrom, J. D., Fernstrom, M. F. and Massoudi, M. S. (1991). "In vivo tyrosine hydroxylation in rat retina: Effect of aspartame ingestion in rats pretreated with p-chlorophenylalanine." Am J Clin Nutr 53(4): 923– 929. Fernstrom, J. D., Fernstrom, M. H. and Gillis, M. A. (1983). "Acute effects of aspartame on large neutral amino acids and monoamines in rat brain." Life Sci 32(14): 1651– 1658. Fernstrom, J. D., Fernstrom, M. H. and Grubb, P. E. (1986). "Effects of aspartame ingestion on the carbohydrate-induced rise in tryptophan hydroxylation rate in rat brain." Am J Clin Nutr 44(2): 195– 205. Filer, L., Baker, G. L. and Stegink, L. (1977). Plasma Aminograms of Infants & Adults Fed an Identical High Protein Meal. Final Report. (G-77-009). G.D. Searle & Co. Filer, L. J. Jr., Baker, G. L. and Stegink, L. D. (1983). "Effect of aspartame loading on plasma and erythrocyte free amino acid concentrations in one-year-old infants." J Nutr 113(8): 1591– 1599. Flamm, W. G. (1997). "Increasing brain tumor rates: is there a link to aspartame?"." J Neuropathol Exp Neurol 56(1): 105– 106. Freedman, M. and Hilton, M. A. (1987). "Consumption of aspartame by heterozygotes for phenylketonuria." J Pediatr 110(4): 662– 663. Freeman, G., Sobotka, T. and Hattan, D. (1990). "Acute effects of aspartame on concentrations of brain amines and their metabolites in selected brain regions of Fischer 344 and Sprague-Dawley rats." Drug Chem Toxicol 13(2–3): 113– 133. Frey, G. H. (1976). "Use of aspartame by apparently healthy children and adolescents." J Toxicol Environ Health 2(2): 401– 415. Frey, G. H. (N/K-a). Long-term Tolerance of Aspartame by Normal Children and Adolescents. G.D. Searle & Co. Frey, G. H. (N/K-b). Long-term Tolerance of Aspartame by Normal Adults. (G-73-001). G.D. Searle & Co. Gallus, S., Scotti, L., Negri, E., Talamini, R., Franceschi, S., Montella, M., Giacosa, A., Dal Maso, L. and La Vecchia, C. (2007). "Artificial sweeteners and cancer risk in a network of case-control studies." Ann Oncol 18(1): 40– 44. Garriga, M. M., Berkebile, C. and Metcalfe, D. D. (1991). "A combined single-blind, double-blind, placebo-controlled study to determine the reproducibility of hypersensitivity reactions to aspartame." J Allergy Clin Immunol 87(4): 821– 827. Gaull, G. E. (1985). "Aspartame and seizures." Lancet 2(8469–70): 1431. Gaull, G. E., Coulombe, R. A. and Sharma, R. P. (1986). "Clinical and behavioral effects of aspartame." Toxicol Appl Pharmacol 85(3): 478– 479. Geha, R. (1992a). MultiCenter Clinical Study to Evaluate Allergic Reactions Allegedly Due to Aspartame Consumption. (NSC Study No. N22-86-02-002). The Nutrasweet Company. Geha, R., Buckley, C. E., Greenberger, P., Patterson, R., Polmar, S., Saxon, A., Rohr, A., Yang, W. and Drouin, M. (1993). "Aspartame is no more likely than placebo to cause urticaria/angioedema: results of a multicenter, randomized, double-blind, placebo-controlled, crossover study." J Allergy Clin Immunol 92(4): 513– 520. Geha, R. S. (1992b). "Aspartame-induced lobular panniculitis." J Am Acad Dermatol 26(2 Pt 1): 277– 278. Gilli, G., Schiliro, T., Traversi, D., Pignata, C., Cordara, S. and Carraro, E. (2008). "Formaldehyde adduct to human serum albumin with reference to aspartame intake." Environ Toxicol Pharmacol 25(1): 89– 93. Goerss, A. L., Wagner, G. C. and Hill, W. L. (2000). "Acute effects of aspartame on aggression and neurochemistry of rats." Life Sci 67(11): 1325– 1329. Gombos, K., Varjas, T., Orsos, Z., Polyak, E., Peredi, J., Varga, Z., Nowrasteh, G., Tettinger, A., Mucsi, G. and Ember, I. (2007). "The effect of aspartame administration on oncogene and suppressor gene expressions." In vivo 21(1): 89– 92. Goodman, J. E., Beyer, L. A. and Beck, B. D. (2009). "Comment on "Evaluation of evidence for infection as the mode of action for induction of rat lymphoma" by Caldwell et al. [2008]." Environmental and Molecular Mutagenesis 50(1): 4– 5. Gray, D. M. and Altekruse, S. F. (1998). Summary of Adverse Reactions Attributed to Aspartame. Memorandum from Technical Information Specialist (HFS-728) to Health Hazard Evaluation Board. US Food and Drug Administration. Guiso, G., Caccia, S., Vezzani, A., Stasi, M. A., Salmona, M., Romano, M. and Garattini, S. (1988). "Effect of aspartame on seizures in various models of experimental epilepsy." Toxicol Appl Pharmacol 96(3): 485– 493. Guiso, G., Diomede, L., Romano, M., Caccia, S., Sarati, S. and Salmona, M. (1991). "Effect of tyrosine on the potentiation by aspartame and phenylalanine of metrazole-induced convulsions in rats." Food Chem Toxicol 29(12): 855– 858. Gupta, V., Cochran, C., Parker, T. F., Long, D. L., Ashby, J., Gorman, M. A. and Liepa, G. U. (1989). "Effect of aspartame on plasma amino acid profiles of diabetic patients with chronic renal failure." Am J Clin Nutr 49(6): 1302– 1306. Gurney, J. G., Pogoda, J. M., Holly, E. A., Hecht, S. S. and Preston-Martin, S. (1997). "Aspartame consumption in relation to childhood brain tumor risk: results from a case-control study." J Natl Cancer Inst 89(14): 1072– 1074. Guttler, F. and Lou, H. (1985). "Aspartame may imperil dietary control of phenylketonuria." Lancet 1(8427): 525– 526. Hagiwara, A., Fukushima, S., Kitaori, M., Shibata, M. and Ito, N. (1984). "Effects of three sweeteners on rat urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)-nitrosamine." Gann 75(9): 763– 768. Hailey, J. R. (2004). Lifetime study in rats conducted by the Ramazzini Foundation. Pathology Working Group Chairperson's Report. Halldorsson, T. I., Strom, M., Petersen, S. B. and Olsen, S. F. (2010). "Intake of artificially sweetened soft drinks and risk of preterm delivery: a prospective cohort study in 59,334 Danish pregnant women." Am J Clin Nutr 92(3): 626– 633. Hardcastle, J. E. and Bruch, R. J. (1997). "Effect of L-aspartyl-L-phenylalanine methyl ester on leukotriene biosynthesis in macrophage cells." Prostaglandins Leukot Essent Fatty Acids 57(3): 331– 333. Hardell, L., Mild, K. H., Pahlson, A. and Hallquist, A. (2001). "Ionizing radiation, cellular telephones and the risk for brain tumours." Eur J Cancer Prev 10(6): 523– 529. Härtel, B., Graubaum, H.-J. and Schneider, B. (1993). "Effect of sweetener solutions on insulin secretion and blood glucose level." Ernährungs-Umschau 40: 152– 155. Helali, N. Y., El-Kashef, H., Salem, H., Gamiel, N. and Elmazar, M. M. (1996). "Effect of aspartame on seizure susceptibility and the anticonvulsant action of ethosuximide, valproate and phenytoin in mice." Saudi Pharm. J. 4(3–4): 149– 156. Hemm, R. D., Rao, K. S., Martinez, T. B., Calhoun, D. W. and Mayer, J. E. (N/K). SC-18862: Nine Week Oral Toxicity Study in the Rat. (Pathology-Toxicology Project No. 847S70). Searle Laboratories. Hertelendy, Z. I., Mendenhall, C. L., Rouster, S. D., Marshall, L. and Weesner, R. (1993). "Biochemical and clinical effects of aspartame in patients with chronic, stable alcoholic liver disease." Am J Gastroenterol 88(5): 737– 743. Hill, A. M. and Belsito, D. V. (2003). "Systemic contact dermatitis of the eyelids caused by formaldehyde derived from aspartame?" Contact Dermatitis 49(5): 258– 259. Hjelle, J. J., Dudley, R. E., Marietta, M. P., Sanders, P. G., Dickie, B. C., Brisson, J. and Kotsonis, F. N. (1992). "Plasma concentrations and pharmacokinetics of phenylalanine in rats and mice administered aspartame." Pharmacology 44(1): 48– 60. Hoffman, R. S., McGinn, T. and Romano, F. (N/K). Short Term Tolerance of Aspartame by Obese Adults. G.D Searle & Co. Hoffman, R. S. and Romano, F. (N/K). Long Term Tolerance of Aspartame by Obese Adults. G.D Searle & Co. Holder, M. D. (1989). "Effects of perinatal exposure to aspartame on rat pups." Neurotoxicol Teratol 11(1): 1– 6. Holder, M. D. and Yirmiya, R. (1989). "Behavioral assessment of the toxicity of aspartame." Pharmacol Biochem Behav 32(1): 17– 26. Hooper, N. M., Hesp, R. J. and Tieku, S. (1994). "Metabolism of aspartame by human and pig intestinal microvillar peptidases." Biochem J 298 Pt 3: 635– 639. Hoover, R. N. and Strasser, P. H. (1980). "Artificial sweeteners and human bladder cancer. Preliminary results." Lancet 1(8173): 837– 840. Horwitz, D. (1988). Effects of Aspartame Ingestion Without Food on Serum Glucose, Insulin, and Glucagon Concentrations in Normal Subjects and Subjects with Diabetes. Documen
Referência(s)